Your browser is no longer supported. Please, upgrade your browser.
Settings
GNCA Genocea Biosciences, Inc. daily Stock Chart
GNCA [NASD]
Genocea Biosciences, Inc.
Index- P/E- EPS (ttm)-0.29 Insider Own0.20% Shs Outstand116.40M Perf Week-23.55%
Market Cap494.70M Forward P/E- EPS next Y-0.35 Insider Trans- Shs Float99.93M Perf Month-23.52%
Income-27.50M PEG- EPS next Q-0.09 Inst Own54.40% Short Float1.37% Perf Quarter-20.54%
Sales- P/S- EPS this Y83.00% Inst Trans25.29% Short Ratio20.93 Perf Half Y-7.94%
Book/sh0.05 P/B85.00 EPS next Y16.70% ROA-70.60% Target Price3.58 Perf Year-43.18%
Cash/sh0.25 P/C17.06 EPS next 5Y- ROE-353.20% 52W Range2.24 - 8.16 Perf YTD85.23%
Dividend- P/FCF- EPS past 5Y23.70% ROI- 52W High-47.92% Beta2.96
Dividend %- Quick Ratio2.50 Sales past 5Y- Gross Margin- 52W Low89.73% ATR0.43
Employees61 Current Ratio2.50 Sales Q/Q- Oper. Margin- RSI (14)27.67 Volatility10.64% 8.65%
OptionableYes Debt/Eq2.56 EPS Q/Q31.40% Profit Margin- Rel Volume1.01 Prev Close4.45
ShortableYes LT Debt/Eq1.45 EarningsApr 30 BMO Payout- Avg Volume65.61K Price4.25
Recom1.70 SMA20-22.85% SMA50-21.93% SMA200-15.62% Volume66,458 Change-4.49%
Mar-01-19Reiterated Needham Buy
Feb-06-18Upgrade Needham Hold → Buy $3
Sep-27-17Downgrade Needham Buy → Hold
Sep-26-17Downgrade Stifel Buy → Hold $15 → $2.50
Jul-25-17Upgrade Needham Hold → Buy $12
Feb-17-17Downgrade Needham Buy → Hold
Apr-01-16Reiterated Stifel Buy $11 → $13
Dec-17-15Initiated UBS Buy $15
Oct-20-15Reiterated Needham Buy $22 → $15
Oct-19-15Reiterated FBR Capital Outperform $20 → $17
Mar-05-14Initiated Needham Buy $22
Mar-03-14Initiated Stifel Buy $25
May-23-19 05:34PM  Edited Transcript of GNCA earnings conference call or presentation 30-Apr-19 1:00pm GMT Thomson Reuters StreetEvents
May-16-19 01:00PM  Genocea Announces Research Collaboration with Iovance to Explore Development of Neoantigen-Targeted TIL (Tumor-Infiltrating Lymphocyte) Products GlobeNewswire
08:00AM  Genocea Announces Positive Interim Immunogenicity Data from GEN-009 Neoantigen Vaccine Phase 1/2a Clinical Trial GlobeNewswire
Apr-30-19 08:13AM  Genocea Biosciences: 1Q Earnings Snapshot Associated Press -7.88%
08:00AM  Genocea Provides Corporate Update, Including First-Quarter 2019 Financial Results GlobeNewswire
Apr-23-19 08:00AM  Genocea to Host Quarterly Corporate Update Conference Call & Webcast on April 30th at 9:00 am ET GlobeNewswire
Apr-03-19 04:01PM  Genocea to Present at 18th Annual Needham Healthcare Conference GlobeNewswire +9.57%
Apr-02-19 01:00PM  Genocea Presents Data at AACR 2019 Supporting Utility of ATLAS Platform in Predicting Melanoma Patient Response to Immune Checkpoint Inhibitors GlobeNewswire
Mar-20-19 10:38AM  Top Ranked Momentum Stocks to Buy for March 20th Zacks
Mar-19-19 11:52AM  Edited Transcript of GNCA earnings conference call or presentation 28-Feb-19 2:00pm GMT Thomson Reuters StreetEvents
Mar-13-19 08:23AM  Will Genocea Biosciences Continue to Surge Higher? Zacks
Mar-07-19 08:18AM  Top Ranked Momentum Stocks to Buy for March 7th Zacks
Mar-06-19 08:05AM  Genocea to Present at the Cowen & Company 39th Annual Health Care Conference GlobeNewswire -5.71%
Feb-28-19 08:00AM  Genocea Reports Fourth Quarter 2018 Results and Announces Hiring of New Chief Financial Officer GlobeNewswire -18.89%
Feb-21-19 08:00AM  Genocea to Host Quarterly Corporate Update Conference Call & Webcast on February 28 at 9:00 am ET GlobeNewswire +6.84%
Feb-12-19 08:30AM  Genocea Announces Private Placement Financing of Up to $39 Million GlobeNewswire +8.21%
Jan-30-19 02:21PM  How Does Investing In Genocea Biosciences, Inc. (NASDAQ:GNCA) Impact The Volatility Of Your Portfolio? Simply Wall St. +12.50%
Jan-02-19 11:55AM  These 4 Healthcare Stocks Are Kicking Off The New Year With A Bang ACCESSWIRE +46.44%
08:00AM  Genocea Doses First Patients and Completes Enrollment in Part A of Phase 1/2a Clinical Trial for Neoantigen Vaccine Candidate GEN-009 GlobeNewswire
Dec-14-18 12:14PM  Read This Before Selling Genocea Biosciences, Inc. (NASDAQ:GNCA) Shares Simply Wall St.
Dec-10-18 08:00AM  Genocea Appoints Girish Aakalu, Ph.D., Chief Business Officer GlobeNewswire
Nov-27-18 08:40AM  Detailed Research: Economic Perspectives on Genocea Biosciences, Big Lots, SemGroup, Conn's, Mimecast, and Neos Therapeutics What Drives Growth in Today's Competitive Landscape GlobeNewswire
Nov-15-18 08:00AM  Genocea To Host a Key Opinion Leader Event November 26th on Latest Advances in Personalized Cancer Immunotherapies GlobeNewswire
Nov-06-18 07:10PM  Edited Transcript of GNCA earnings conference call or presentation 1-Nov-18 1:00pm GMT Thomson Reuters StreetEvents
08:00AM  Genocea Unveils Possible Mechanism for Tumor Resistance to Immunotherapy at Society for Immunotherapy of Cancers (SITC) 33rd Annual Meeting GlobeNewswire
Nov-01-18 08:35AM  Genocea Biosciences: 3Q Earnings Snapshot Associated Press
08:00AM  Genocea Reports Third Quarter 2018 Financial and Operating Results GlobeNewswire
Oct-25-18 08:05AM  Genocea to Host Third Quarter 2018 Financial Results Conference Call & Webcast on November 1, 2018 at 9:00 a.m. ET GlobeNewswire
Oct-19-18 03:07PM  Do Institutions Own Shares In Genocea Biosciences Inc (NASDAQ:GNCA)? Simply Wall St.
Oct-11-18 08:35AM  Analysis: Positioning to Benefit within Genocea Biosciences, Retail Properties of America, Hawkins, QUANTENNA COMMS, Hillenbrand, and Herman Miller Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Oct-09-18 08:35AM  Genocea Announces Upcoming Presentations at SITC 2018 GlobeNewswire
Oct-01-18 07:30AM  Genocea Strengthens Leadership Team: Thomas Davis, M.D. Appointed Chief Medical Officer; Derek Meisner, J.D. Joins as General Counsel GlobeNewswire
Sep-24-18 08:02AM  Genocea to Present at Two October Investor Conferences GlobeNewswire +10.91%
Aug-29-18 08:05AM  Genocea to Present at Two September Investor Conferences GlobeNewswire
Aug-16-18 05:41AM  Genocea Biosciences Sees Hammer Chart Pattern: Time to Buy? Zacks +5.80%
Aug-07-18 07:35AM  Consolidated Research: 2018 Summary Expectations for Genocea Biosciences, Hawkins, Landstar System, American Assets Trust, TriCo Bancshares, and LogMein Fundamental Analysis, Key Performance Indications GlobeNewswire
Aug-02-18 03:18PM  Edited Transcript of GNCA earnings conference call or presentation 2-Aug-18 1:00pm GMT Thomson Reuters StreetEvents +14.53%
09:58AM  Genocea Biosciences: 2Q Earnings Snapshot Associated Press
08:04AM  Genocea Reports Second Quarter 2018 Financial and Operating Results GlobeNewswire
07:00AM  Genocea Biosciences, Inc. to Host Earnings Call ACCESSWIRE
Jul-26-18 08:05AM  Genocea to Host Second Quarter 2018 Financial Results Conference Call & Webcast on August 2, 2018 at 9:00 a.m. ET GlobeNewswire
Jul-11-18 07:35AM  Complimentary Technical Snapshots on Incyte and Three More Biotech Stocks ACCESSWIRE
Jun-01-18 08:04AM  Genocea to Present at Jefferies 2018 Global Healthcare Conference GlobeNewswire
May-10-18 09:02AM  Genocea Biosciences: 1Q Earnings Snapshot Associated Press
07:59AM  Genocea Reports First Quarter 2018 Financial and Operating Results GlobeNewswire
May-04-18 08:04AM  Genocea to Host First Quarter 2018 Financial Results Conference Call & Webcast on May 10, 2018 at 9 a.m. ET GlobeNewswire
May-02-18 07:45AM  Market Trends Toward New Normal in City Office REIT, Malibu Boats, Vical, Renasant, Genocea Biosciences, and Lindsay Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire +7.21%
Apr-30-18 08:04AM  Genocea Files Investigational New Drug Application for Neoantigen Cancer Vaccine Candidate GEN-009 GlobeNewswire
Apr-18-18 09:01AM  Genocea Presents Data at AACR Annual Meeting Further Highlighting Advantages of ATLAS Platform in Identification of Neoantigens over in silico Methods GlobeNewswire
Apr-09-18 08:05AM  Genocea to Present Data at Upcoming AACR Annual Meeting Further Highlighting ATLAS Platform Ability to Identify and Characterize Neoantigens for Cancer Vaccines GlobeNewswire
Mar-27-18 05:23AM  Genocea Biosciences a Good Buy and Hold Stock FX Empire -7.89%
Mar-12-18 05:39PM  Genocea Appoints Narinder Singh as SVP Pharmaceutical Sciences & Manufacturing GlobeNewswire
Mar-08-18 03:23PM  HC Wainwright Takes Bullish Stance On Two Cancer-Focused Pharma Companies Benzinga +7.66%
Mar-05-18 08:00AM  Genocea to Present at Two March Investor Conferences GlobeNewswire
Mar-02-18 07:30AM  Research Report Identifies AutoZone, Highwoods Properties, Virtu Financial, Genocea Biosciences, LGI Homes, and Agios Pharmaceuticals with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-23-18 05:13PM  Genocea Biosciences Inc (NASDAQ:GNCA): Does The -14.40% Earnings Decline Make It An Underperformer? Simply Wall St.
Feb-15-18 08:33AM  Genocea Biosciences reports 4Q loss Associated Press
08:00AM  Genocea Reports Fourth Quarter and Full-Year 2017 Financial Results GlobeNewswire
06:50AM  Genocea Biosciences, Inc. to Host Earnings Call ACCESSWIRE
Feb-12-18 04:01PM  NEA Partner Ali Behbahani, M.D. Joins Genocea Biosciences Board of Directors GlobeNewswire +7.53%
Feb-08-18 08:00AM  Genocea to Host Fourth Quarter and Year End 2017 Financial Results Conference Call & Webcast on February 15, 2018 at 9 a.m. ET GlobeNewswire
Jan-17-18 08:40AM  Genocea Biosciences, Inc. Announces Pricing of $55 Million Concurrent Public Offerings GlobeNewswire -25.00%
Jan-16-18 04:01PM  Genocea Biosciences, Inc. Announces Proposed Concurrent Public Offerings of Common Stock and Class A Warrants and Series A Convertible Preferred Stock and Class A Warrants GlobeNewswire
Jan-08-18 07:30AM  Factors of Influence in 2018, Key Indicators and Opportunity within Kelly Services, Genocea Biosciences, Balchem, Federal Signal, Marriott Vacations Worldwide, and International Bancshares New Research Emphasizes Economic Growth GlobeNewswire -5.36%
Jan-03-18 09:58AM  How Do Analysts See Genocea Biosciences Inc (NASDAQ:GNCA) Performing Over The Couple Of Years? Simply Wall St.
Jan-02-18 02:54PM  Glancy Prongay & Murray Reminds Investors of the January 2, 2018 Deadline in the Class Action Lawsuit Against Genocea Biosciences, Inc. (GNCA) Business Wire +6.03%
Dec-28-17 01:41PM  The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Genocea Biosciences, Inc. Shareholders and a Lead Plaintiff Deadline of January 2, 2018 ACCESSWIRE -5.51%
Dec-27-17 08:35PM  Robbins Arroyo LLP: Genocea Biosciences, Inc. (GNCA) Misled Shareholders According to a Recently Filed Class Action Business Wire
04:54PM  GENOCEA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $500,000 In Genocea Biosciences, Inc. To Contact The Firm Business Wire
02:25PM  Scott+Scott, Attorneys at Law, LLP Reminds Investors that the Lead Plaintiff Deadline in Genocea Biosciences, Inc. (GNCA) Class Action is January 2nd Business Wire
12:15PM  GNCA SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Genocea Biosciences, Inc. and a Lead Plaintiff Deadline of January 2, 2018 ACCESSWIRE
10:08AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Genocea Bioscience, Inc. (GNCA) & Lead Plaintiff Deadline - January 2, 2018 ACCESSWIRE
Dec-23-17 08:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Genocea Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline GNCA GlobeNewswire
Dec-22-17 03:20PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Genocea Biosciences, Inc. - GNCA PR Newswire
Dec-20-17 10:51AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint on Behalf of Genocea Biosciences, Inc. Shareholders and Lead Plaintiff Deadline Set for January 2, 2018 GNCA ACCESSWIRE
10:08AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Genocea Bioscience, Inc. (GNCA) & Lead Plaintiff Deadline - January 2, 2018 ACCESSWIRE
Dec-18-17 02:12PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Genocea Biosciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2018 - GNCA ACCESSWIRE
Dec-16-17 08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Genocea Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline - GNCA PR Newswire
Dec-13-17 02:30PM  The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Genocea Biosciences, Inc. Shareholders and a Lead Plaintiff Deadline of January 2, 2018 GlobeNewswire
10:07AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Genocea Bioscience, Inc. (GNCA) & Lead Plaintiff Deadline: January 2, 2018 ACCESSWIRE
Dec-12-17 05:27PM  GENOCEA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $500,000 In Genocea Biosciences, Inc. To Contact The Firm ACCESSWIRE
05:07PM  GNCA LOSS NOTICE: Rosen Law Firm Reminds Genocea Biosciences, Inc. Investors of Important Deadline in Class Action GNCA GlobeNewswire
01:40PM  Scott+Scott, Attorneys at Law, LLP Filed Class Action Against Genocea Biosciences, Inc. (GNCA) Lead Plaintiff Deadline is January 2nd Business Wire
Dec-11-17 04:00PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Genocea Biosciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2018 - GNCA ACCESSWIRE
02:57PM  DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Genocea Bioscience, Inc. to Contact the Firm Business Wire
Dec-06-17 02:00PM  GNCA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Genocea Biosciences, Inc. and a Lead Plaintiff Deadline of January 2, 2018 GlobeNewswire -5.36%
10:07AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Genocea Bioscience, Inc. (GNCA) & Lead Plaintiff Deadline: January 2, 2018 ACCESSWIRE
Dec-05-17 06:02PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Genocea Biosciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2018 GNCA GlobeNewswire -5.08%
04:30PM  IMPORTANT GENOCEA BIOSCIENCES, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of investors who purchased and suffered losses in Genocea Biosciences, Inc. GlobeNewswire
Dec-04-17 03:00PM  The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Genocea Biosciences, Inc. Shareholders and a Lead Plaintiff Deadline of January 2, 2018 ACCESSWIRE
Dec-02-17 08:43PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Genocea Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline - GNCA ACCESSWIRE
Dec-01-17 03:10AM  EQUITY ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Genocea Biosciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2018 - GNCA ACCESSWIRE
Nov-30-17 05:11PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Genocea Bioscience, Inc. (NASDAQ: GNCA) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit GlobeNewswire +5.17%
02:10AM  GNCA EQUITY ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Genocea Biosciences, Inc. and a Lead Plaintiff Deadline of January 2, 2018 ACCESSWIRE
Nov-29-17 10:06AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Genocea Bioscience, Inc. (GNCA) & Lead Plaintiff Deadline: January 2, 2018 ACCESSWIRE
02:10AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Genocea Biosciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2018 - GNCA ACCESSWIRE
Nov-28-17 03:00PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Genocea Biosciences, Inc. GNCA GlobeNewswire
03:00PM  The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Genocea Biosciences, Inc. Shareholders and a Lead Plaintiff Deadline of January 2, 2018 Business Wire
12:14PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Genocea Biosciences, Inc. Investors (GNCA) Business Wire
Nov-27-17 02:30PM  GNCA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Genocea Biosciences, Inc. and a Lead Plaintiff Deadline of January 2, 2018 Business Wire -6.98%
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer vaccines. The company uses its proprietary discovery platform, ATLAS, to recall a patient's pre-existing CD4+ and CD8+ T cell immune responses to tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. Its lead immuno-oncology program is GEN-009, an adjuvanted neoantigen peptide vaccine candidate, which is in preclinical stage, designed to direct a patient's immune system to attack tumor. The company is also seeking partners to develop cancer vaccines targeting tumor-associated antigens and a vaccine targeting cancers caused by Epstein-Barr virus. Genocea Biosciences, Inc. was founded in 2006 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Singh NarinderjeetSENIOR VP, PS&MMay 08Option Exercise0.547,2913,93761,873May 09 12:55 PM
Singh NarinderjeetSENIOR VP, PS&MApr 11Option Exercise0.547,2913,93754,582Apr 12 12:11 PM
Singh NarinderjeetSENIOR VP, PS&MMar 18Option Exercise0.547,2913,93747,291Mar 19 10:07 AM
Clark William DPresident and CEOMar 15Option Exercise0.5415,0008,100119,931Mar 18 01:34 PM
Sonsini Peter W.10% OwnerFeb 14Buy0.479,948,2694,688,61934,948,269Feb 19 05:05 PM
MAKOWER JOSHUA10% OwnerFeb 14Buy0.479,948,2694,688,61934,948,269Feb 19 05:03 PM
MOTT DAVID M10% OwnerFeb 14Buy0.479,948,2694,688,61934,948,269Feb 19 05:04 PM
SANDELL SCOTT D10% OwnerFeb 14Buy0.479,948,2694,688,61934,948,269Feb 19 05:04 PM
Florence Anthony A. Jr.10% OwnerFeb 14Buy0.479,948,2694,688,61934,948,269Feb 19 05:02 PM
Makhzoumi Mohamad10% OwnerFeb 14Buy0.479,948,2694,688,61934,948,269Feb 19 05:03 PM
Behbahani AliDirectorFeb 14Buy0.479,948,2694,688,61934,948,269Feb 19 05:02 PM
Chang Carmen10% OwnerFeb 14Buy0.479,948,2694,688,61934,948,269Feb 19 05:02 PM
BARRIS PETER J10% OwnerFeb 14Buy0.479,948,2694,688,61934,948,269Feb 19 05:00 PM
BASKETT FOREST10% OwnerFeb 14Buy0.479,948,2694,688,61934,948,269Feb 19 05:01 PM
New Enterprise Associates 16, 10% OwnerFeb 14Buy0.479,948,2694,688,61934,948,269Feb 19 05:00 PM
Alfieri MichaelPrinciple Financial OfficerSep 13Buy0.5410,0005,40010,000Sep 14 05:13 PM
Siber GeorgeDirectorSep 07Buy0.6113,4008,174165,417Sep 24 08:13 PM
Siber GeorgeDirectorSep 06Buy0.6125,00015,250152,017Sep 24 08:13 PM
Siber GeorgeDirectorSep 05Buy0.6225,00015,500127,017Sep 24 08:13 PM
Siber GeorgeDirectorSep 04Buy0.6225,00015,500102,017Sep 24 08:13 PM
Siber GeorgeDirectorAug 31Buy0.6125,00015,25077,017Sep 24 08:13 PM
Siber GeorgeDirectorAug 30Buy0.6125,00015,25052,017Sep 24 08:13 PM
Siber GeorgeDirectorAug 29Buy0.6125,00015,25027,017Sep 24 08:13 PM